Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Colorectal Neoplasms × niraparib × Clear all

Phase

Status

Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 4 Prostatic Neoplasms 2 Breast Neoplasms 2 Sarcoma 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 MMR-D/MSI-H Colorectal Cancers 1 Leiomyosarcoma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1

Interventions

Oxaliplatin 18 Fluorouracil 18 Leucovorin 17 Bevacizumab 15 Irinotecan 12 Cetuximab 12 Capecitabine 8 Nivolumab 5 regorafenib 4 aflibercept 4 Radiotherapy 4 pembrolizumab 3 Radiosurgery 3 Neoadjuvant Therapy 3 Magnetic Resonance Spectroscopy 3 Drug Therapy 3 Cyclophosphamide 3 Biopsy 3 trifluridine tipiracil drug combination 2 tremelimumab 2 tislelizumab 2 futuximab 2 fludarabine 2 durvalumab 2 avelumab 2 aldesleukin 2 Trastuzumab 2 Surgical Procedures, Operative 2 Specimen Handling 2 S 1 (combination) 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05412706 2023-09-08

Bohème

Ospedale Policlinico San Martino

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡